Arama Sonuçları - Wolfgang Schmitt

Sonuçları Daraltın
  1. 1
    Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization

    Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization Yazar: Jan Budczies, Frederick Klauschen, Bruno V. Sinn, Balázs Győrffy, Wolfgang Schmitt, Silvia Darb‐Esfahani, Carsten Denkert

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Expression of mitogen‐activated protein kinase phosphatase‐1 (MKP‐1) in primary human ovarian carcinoma

    Expression of mitogen‐activated protein kinase phosphatase‐1 (MKP‐1) in primary human ovarian carcinoma Yazar: Carsten Denkert, Wolfgang Schmitt, Stefan Berger, Angela Reles, Sören Pest, Antje Siegert, W. Lichtenegger, Manfred Dietel, Steffen Hauptmann

    Baskı/Yayın Bilgisi 2002
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma

    Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma Yazar: Anja Schmidt, M Bloechinger, Andreas Weber, Jens T. Siveke, Stefan von Delius, Christian Prinz, Wolfgang Schmitt, RM Schmid, Bruno Neu

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Reliability of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry in Breast Core Needle Biopsies

    Reliability of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry in Breast Core Needle Biopsies Yazar: Annette Lebeau, Andreas Turzynski, Susanne Braun, Wera Behrhof, Barbara Fleige, Wolfgang Schmitt, Tobias Grob, Lia Burkhardt, D. Hölzel, Christian Jackisch, Christoph Thomssen, Volkmar Müller, Michael Untch

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    S3-Leitlinie – Kolorektales Karzinom

    S3-Leitlinie – Kolorektales Karzinom Yazar: Wolff Schmiegel, Barbara Buchberger, Markus Follmann, Ullrich Graeven, Volker Heinemann, Thomas Langer, Monika Nothacker, Rainer Porschen, Claus Rödel, Thomas Rösch, Wolfgang Schmitt, Simone Wesselmann, Christian Pox

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  6. 6
    High-grade ovarian serous carcinoma patients exhibit profound alterations in lipid metabolism

    High-grade ovarian serous carcinoma patients exhibit profound alterations in lipid metabolism Yazar: Elena Ioana Braicu, Silvia Darb‐Esfahani, Wolfgang Schmitt, Kaisa M. Koistinen, Laura Heiskanen, Päivi Pöhö, Jan Budczies, Marc Kuhberg, Manfred Dietel, Christian Frezza, Carsten Denkert, Jalid Sehouli, Mika Hilvo

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Accumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas

    Accumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas Yazar: Mika Hilvo, Inês de Santiago, Peddinti Gopalacharyulu, Wolfgang Schmitt, Jan Budczies, Marc Kuhberg, Manfred Dietel, Tero Aittokallio, Florian Markowetz, Carsten Denkert, Jalid Sehouli, Christian Frezza, Silvia Darb‐Esfahani, Elena Ioana Braicu

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  8. 8
    S3-Leitlinie „Kolorektales Karzinom” – Aktualisierung 2008

    S3-Leitlinie „Kolorektales Karzinom” – Aktualisierung 2008 Yazar: Wolff Schmiegel, Anke Reinacher‐Schick, Dirk Arnold, U. Graeven, Volker Heinemann, Rainer Porschen, J F Riemann, Claus Rödel, R. Sauer, M Wieser, Wolfgang Schmitt, Hans‐Joachim Schmoll, T Seufferlein, I. Kopp, Christian Pox

    Baskı/Yayın Bilgisi 2008
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Standardized Ki67 Diagnostics Using Automated Scoring—Clinical Validation in the GeparTrio Breast Cancer Study

    Standardized Ki67 Diagnostics Using Automated Scoring—Clinical Validation in the GeparTrio Breast Cancer Study Yazar: Frederick Klauschen, Stephan Wienert, Wolfgang Schmitt, Sibylle Loibl, Bernd Gerber, Jens‐Uwe Blohmer, Jens Huober, Thomas Rüdiger, E Erbstösser, Keyur Mehta, Bianca Lederer, Manfred Dietel, Carsten Denkert, Gϋnter von Minckwitz

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers

    Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers Yazar: E. Bayerdörffer, Stephan Miehlke, G. A. Mannes, Albrecht Sommer, W. Höchter, J. Weingart, Walter Heldwein, Hermann Klann, Thomas Simon, Wolfgang Schmitt, Elke Bästlein, A. Eimiller, Rudolf Hatz, Norbert Lehn, P. Dirschedl, Manfred Stolte

    Baskı/Yayın Bilgisi 1995
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  11. 11
    Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial

    Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial Yazar: Carsten Denkert, Sibylle Loibl, Berit Müller, Holger Eidtmann, Wolfgang Schmitt, W. Eiermann, B. Gerber, Hans Tesch, J. Hilfrich, Jens Huober, Tanja Fehm, Jana Barinoff, Christian Jackisch, Judith Prinzler, Thomas Rüdiger, E Erbstösser, Jens‐Uwe Blohmer, Jan Budczies, K. Mehta, Gϋnter von Minckwitz

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer

    Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer Yazar: Barbara Ingold Heppner, Michael Untch, Carsten Denkert, Berit M. Pfitzner, Bianca Lederer, Wolfgang Schmitt, Holger Eidtmann, Peter A. Fasching, Hans Tesch, Christine Solbach, Mahdi Rezai, Dirk M. Zahm, Frank Holms, Manfred Glados, Petra Krabisch, Esther Heck, Angelika Ober, Petra Lorenz, Kurt Diebold, Jörg-Olaf Habeck, Sibylle Loibl

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer

    Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer Yazar: Christopher Maximilian Arends, K Kopp, Raphael Hablesreiter, Natàlia Estrada, Friederike Christen, Ute M. Moll, Robert Zeillinger, Wolfgang Schmitt, Jalid Sehouli, Hagen Kulbe, Maximilian Fleischmann, Isabelle Ray‐Coquard, Alain G. Zeimet, Francesco Raspagliesi, Claudio Zamagni, Ignace Vergote, Domenica Lorusso, Nicole Concin, Lars Bullinger, Elena Ioana Braicu, Frédérik Damm

    Baskı/Yayın Bilgisi 2024
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer

    Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer Yazar: Gϋnter von Minckwitz, Wolfgang Schmitt, Sibylle Loibl, Berit Müller, Jens‐Uwe Blohmer, Bruno V. Sinn, Holger Eidtmann, W. Eiermann, Bernd Gerber, Hans Tesch, J. Hilfrich, Jens Huober, Tanja Fehm, Jana Barinoff, Thomas Rüdiger, Erhard Erbstoesser, Peter A. Fasching, Thomas Karn, Volkmar Müller, Christian Jackisch, Carsten Denkert

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study)

    Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study) Yazar: Peter A. Fasching, Theresa Link, Jan Hauke, Fenja Seither, Christian Jackisch, Peter Klare, Sabine Schmatloch, Claus Hanusch, Jens Huober, Andrea Stefek, Sabine Seiler, Wolfgang Schmitt, Christoph Uleer, Gabriele Doering, Kerstin Rhiem, Andreas Schneeweiß, Knut Engels, Carsten Denkert, Rita K. Schmutzler, Eric Hahnen, Michael Untch, Nicole Burchardi, Jens‐Uwe Blohmer, Sibylle Loibl

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

    Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer Yazar: Bruno V. Sinn, Sibylle Loibl, Claus Hanusch, Dirk-Michael Zahm, Hans‐Peter Sinn, Michael Untch, Karsten E. Weber, Thomas Karn, Clemens Becker, Frederik Marmé, Wolfgang Schmitt, Volkmar Müller, Christian Schem, Denise Treue, Elmar Stickeler, Frederik Klauschen, Nicole Burchardi, Jenny Furlanetto, Marion van Mackelenbergh, Peter A. Fasching, Andreas Schneeweiß, Carsten Denkert

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Role of<i>TP53</i>mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy

    Role of<i>TP53</i>mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy Yazar: Silvia Darb‐Esfahani, Carsten Denkert, Albrecht Stenzinger, Christoph Salat, Bruno V. Sinn, Christian Schem, Volker Endris, Peter Klare, Wolfgang Schmitt, Jens‐Uwe Blohmer, Wilko Weichert, Markus Möbs, Hans Tesch, Sherko Kümmel, Hans‐Peter Sinn, Christian Jackisch, Manfred Dietel, Toralf Reimer, Sherene Loi, Michael Untch, Gϋnter von Minckwitz, Valentina Nekljudova, Sibylle Loibl

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study

    A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and b... Yazar: S. Loibl, Michael Untch, Nicole Burchardi, Jens Huober, Bruno V. Sinn, Jens‐Uwe Blohmer, Eva‐Maria Grischke, Jenny Furlanetto, Hans Tesch, Claus Hanusch, Knut Engels, Mahdi Rezai, Christian Jackisch, Wolfgang Schmitt, Gϋnter von Minckwitz, Jörg Thomalla, Sherko Kümmel, Beate Rautenberg, Peter A. Fasching, Karsten E. Weber, Kerstin Rhiem, Carsten Denkert, Andreas Schneeweiß

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial

    Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial Yazar: Sibylle Loibl, Denise Treue, Jan Budczies, Karsten E. Weber, Albrecht Stenzinger, Wolfgang Schmitt, Wilko Weichert, Paul Jank, Jenny Furlanetto, Frederick Klauschen, Thomas Karn, Nicole Pfarr, Gϋnter von Minckwitz, Markus Möbs, Christian Jackisch, Christine Sers, Andreas Schneeweiß, Peter A. Fasching, Christian Schem, Michael Hummel, Marion van Mackelenbergh, Valentina Nekljudova, Michael Untch, Carsten Denkert

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  20. 20
    Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo

    Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo Yazar: Thomas Karn, Carsten Denkert, Karsten E. Weber, Uwe Holtrich, Claus Hanusch, Bruno V. Sinn, Brandon W. Higgs, Paul Jank, Hans‐Peter Sinn, Jens Huober, Christoph Becker, Jens‐Uwe Blohmer, Frederik Marmé, Wolfgang Schmitt, Song Wu, Marion van Mackelenbergh, Volkmar Müller, Christian Schem, Elmar Stickeler, Peter A. Fasching, Christian Jackisch, Michael Untch, Andreas Schneeweiß, Sibylle Loibl

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: